AWS
UTHR icon

Atria Wealth Solutions’s United Therapeutics UTHR Stock Holding History

Atria Wealth Solutions’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,169
Closed -$412K – 2086
2024
Q4 		$412K Buy
+1,169
New +$430K ﹤0.01% 1373

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Atria Wealth Solutions's UTHR Position: Q1 2025 in Review

Atria Wealth Solutions sold out of United Therapeutics (UTHR) in Q1 2025, closing a stake of 1,169 shares — an estimated $412K sold.

Atria Wealth Solutions first reported a position in UTHR in Q4 2024 and held it in 1 quarter. The position peaked at $412K in Q4 2024. 673 funds tracked by Wall St. Rank hold UTHR as of Q1 2025.

  • Atria Wealth Solutions reported no remaining United Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Atria Wealth Solutions sold 1,169 United Therapeutics shares in Q1 2025, an estimated $412K.
  • Atria Wealth Solutions first reported a position in United Therapeutics in Q4 2024 and held it in 1 quarter.
  • Atria Wealth Solutions's United Therapeutics position peaked at $412K in Q4 2024.
  • 673 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2025.

Based on Atria Wealth Solutions's 13F filing for Q1 2025, filed 9 May 2025.